The global pharmaceutical supply chain was a primary strategic focus at BIO Asia-Taiwan 2026, where international health officials, policy makers, and executives addressed systemic vulnerabilities exposed by recent geopolitical disruptions and public health crises. Over the past three decades, the industry aggressively prioritized cost-efficiency, lean inventory management, and centralized manufacturing. Dr. Johnson Lee, Chairman of … From “Just-in-Time” to “Just-in-Case”: Rewiring the Global Pharma Supply Chain for Ultimate Resilience Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.